Skip to main content
logo
GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.3000
-0.0018 (-0.60%)
At close: Aug 28, 2026, 4:00 PM EDT
0.308496
+0.0085 (2.83%)
After-hours: Aug 28, 2026, 7:05 PM EDT

GT Biopharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-16.34-12.42-14.36-13.58-21.26-57.52
Net Income
-11.38-34.45-13.16-7.6-20.88-58.01
Earnings Per Share
-0.53-6.25-6.94-5.64-19.66-61.81
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.966.813.9513.9716.5131.98
Total Debt
---0.060.170.03
Net Cash (Debt)
4.966.813.9513.9116.3331.95
Net Cash Growth
-5.13%72.39%-71.60%-14.82%-48.87%-
Net Cash Per Share
0.231.242.0810.3215.3834.04

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-14.43-12.91-12.9-8.85-15.22-15.61
Capital Expenditures
------
Free Cash Flow
-14.43-12.91-12.9-8.85-15.22-15.61
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------